The use of digital health to deliver healthcare has seen unprecedented growth over the past few years, with significant acceleration due to the COVID-19 Public Health Emergency (PHE). As patients seek ways to empower themselves and take more control of their health and well-being, this demand is being met by flexible and innovative tools and technologies. The latest health technology advancements in diagnostics, treatment, and ongoing patient management have the potential to improve health and disease outcomes more than ever before. Companies in this industry have also raised a record-setting amount of capital, particularly during the PHE.
Like many other segments that go through rapid growth and innovation, the industry faces a complex and shifting set of laws and regulations. While many temporary waivers and policies during the PHE created an ecosystem allowing companies to flourish, companies in this space should begin to expect heightened scrutiny from various regulators as we turn the page to 2022.
Please see full publication below for more information.